Posted inHealth
Novo Nordisk to Cut Ozempic, Wegovy US List Prices Up to 50% in Major GLP-1 Reset
Novo Nordisk is preparing one of the biggest pricing resets in the GLP-1 market. The Danish drugmaker plans to cut U.S. list prices for its blockbuster diabetes and weight-loss injections…






